Proactive Investors - Run By Investors For Investors

Porta strong end to year boosts profits; 2016 shaping up well

In a trading update, the marketing and communications specialist said headline EBITDA was up 40% in the second half.
Porta strong end to year boosts profits; 2016 shaping up well
The figures are starting to stack up as the company enjoyed a strong end to the year.

Porta (LON:PTCM) finished the year on a high note and expects the momentum to carry into 2016.

In a trading update, the marketing and communications specialist said headline EBITDA was up 40% in the second half and will be ahead 17% for 2015 as a whole.

The strong performance has come despite the closure of the Brussels and Frankfurt offices as well as the closure of “non-performing” companies and account groups.

Exceptional costs are expected to be high as a result of the reorganisation, Porta said.

The appointment of Steffan Williams as managing director in September is already having a direct and positive impact on the financial PR arm Newgate in particular, which snagged the account to represent mining major Glencore.

“Prospects for the current year look very exciting given the internal changes made and the quality of new senior recruits,” Porta told investors.

“New business levels and opportunities are extremely buoyant and we are looking at a number of potential acquisitions that will accelerate our growth plans if successful.”

View full PTCM profile View Profile

Porta Communications PLC Timeline

Related Articles

Apollo 11
February 22 2018
Immersive VR, a technology company focused on the education space, was the first company Sure backed
Marketing and public relations
April 04 2018
"Our Beyond, MBooth and Publitek agencies have been stand-out performers, whilst we have achieved solid performances pretty much across the portfolio"
ipad
September 19 2018
“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use